Cargando…
Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is a poor prognosis disease lacking adequate therapy. We have previously shown that ascorbic acid administration is toxic to MPM cells. Here we evaluated a new combined therapy consisting of ascorbate/epigallocatechin-3-gallate/gemcitabine mixture (called AND, fo...
Autores principales: | Volta, Viviana, Ranzato, Elia, Martinotti, Simona, Gallo, Simone, Russo, Maria Veronica, Mutti, Luciano, Biffo, Stefano, Burlando, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590277/ https://www.ncbi.nlm.nih.gov/pubmed/23526965 http://dx.doi.org/10.1371/journal.pone.0058051 |
Ejemplares similares
-
Epigallocatechin-3-gallate induces mesothelioma cell death via H(2)O(2)—dependent T-type Ca(2+) channel opening
por: Ranzato, Elia, et al.
Publicado: (2012) -
ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100
por: Ranzato, Elia, et al.
Publicado: (2022) -
Aquaporin-6 May Increase the Resistance to Oxidative Stress of Malignant Pleural Mesothelioma Cells
por: Pellavio, Giorgia, et al.
Publicado: (2022) -
Honey exposure stimulates wound repair of human dermal fibroblasts
por: Ranzato, Elia, et al.
Publicado: (2013) -
Targeting Calcium Signalling in Malignant Mesothelioma †
por: Martinotti, Simona, et al.
Publicado: (2019)